AlloCyte Pharmaceuticals AG is a Swiss-based company discovering, developing and commercializing next generation oral integrin modulators of allosteric mode of action protecting the integrity of tissues afflicted by autoimmunity.  The next target milestone is clinical therapeutic proof-of-concept.

Some insights
Location
Canton
Facts & figures
  • Type of organization
    Private company
  • Year of foundation
    2011
  • Number of employees in Switzerland
    1-9
Key business

You may also be interested in